Fennec Pharmaceuticals, Inc. (FENC)
9.81
-0.12
(-1.21%)
USD |
NASDAQ |
May 26, 13:09
Fennec Pharmaceuticals Shareholders Equity (Quarterly) : 37.68M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| CytomX Therapeutics, Inc. | 319.94M |
| Gossamer Bio, Inc. | -161.48M |
| REGENXBIO, Inc. | 21.08M |
| Zymeworks, Inc. | 163.59M |
| Apellis Pharmaceuticals, Inc. | 414.92M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 71.82M |
| Total Liabilities (Quarterly) | 34.15M |
| Current Ratio | 6.977 |
| Net Debt Paydown Yield | 1.70% |